Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Canadian Pacific Kansas City Limited Common Shares (CP) vs Charles River Laboratories Intl. Inc (CRL) Price & Performance

Canadian Pacific Kansas City Limited Common SharesTrade
Charles River Laboratories Intl. IncTrade

Price performance (Past 24H)

Key statistics

Canadian Pacific Kansas City Limited Common Shares vs Charles River Laboratories Intl. Inc — how do they compare? Canadian Pacific Kansas City Limited Common Shares trades at $84.41 (market cap $73.98B), while Charles River Laboratories Intl. Inc trades at $302.47 (market cap $14.23B). The key difference: Canadian Pacific Kansas City Limited Common Shares is far larger — about 5.2× Charles River Laboratories Intl. Inc's market cap, and Canadian Pacific Kansas City Limited Common Shares pays a 0.9% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.

CPCRL
Market Cap
$73.98B$14.23B
Volume
1,669,8281,176,885
Sector
IndustrialsHealth
52-Week High
$96.69$310.77
52-Week Low
$68.88$149.93
Enterprise Value
$91.36B$17.06B
Dividend Yield
0.9%—
Typical Hold Time
—33 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Canadian Pacific Kansas City Limited Common Shares

No Aura AI signal available yet.

Charles River Laboratories Intl. Inc

Charles River Laboratories (CRL) trades at $300.53, up 0.08% on the day, with a bullish technical outlook and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, though it faces profitability challenges with a negative net income margin and ROE. Recent investor day presentations highlighted a strategic plan targeting 5-7% revenue growth and $300 million in savings by 2030, driving positive sentiment.

The outlook is cautiously optimistic, supported by analyst buy ratings and a $305.50 consensus price target, but risks include ongoing margin pressure, volatile non-human primate costs, and a high valuation multiple. Earnings growth and successful execution of the new strategic plan are critical for sustained upside.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CP

No sentiment data available yet.

CRL
0% Buy100% Sell
Avg holding period · 33 Days

About Canadian Pacific Kansas City Limited Common Shares

Canadian Pacific Kansas City operates a freight railway connecting Canada, the United States, and Mexico. The company was formed through the combination of Canadian Pacific and Kansas City Southern.

Read more on CP →

About Charles River Laboratories Intl. Inc

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Read more on CRL →